| mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0028 |
0.9 |
| mRNA |
BEC |
CTRPv2 |
pan-cancer |
AAC |
-0.0058 |
0.9 |
| mRNA |
Bleomycin |
CTRPv2 |
pan-cancer |
AAC |
0.0029 |
0.9 |
| mRNA |
BX-795 |
GDSC1000 |
pan-cancer |
AAC |
-0.0025 |
0.9 |
| mRNA |
NVP-BEZ235 |
CTRPv2 |
pan-cancer |
AAC |
-0.0031 |
0.9 |
| mRNA |
WH-4-023 |
GDSC1000 |
pan-cancer |
AAC |
0.0036 |
0.9 |
| mRNA |
PF-562271 |
GDSC1000 |
pan-cancer |
AAC |
0.0024 |
0.9 |
| mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0035 |
0.9 |
| mRNA |
BRD-K35604418 |
CTRPv2 |
pan-cancer |
AAC |
-0.0025 |
0.9 |
| mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
-0.0034 |
0.9 |